Načítá se...
Chemotherapy for pulmonary large cell neuroendocrine carcinomas: does the regimen matter?
Pulmonary large cell neuroendocrine carcinoma (LCNEC) is rare. Chemotherapy for metastatic LCNEC ranges from small cell lung carcinoma (SCLC) regimens to nonsmall cell lung carcinoma (NSCLC) chemotherapy regimens. We analysed outcomes of chemotherapy treatments for LCNEC. The Netherlands Cancer Regi...
Uloženo v:
| Vydáno v: | Eur Respir J |
|---|---|
| Hlavní autoři: | , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
European Respiratory Society
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5898951/ https://ncbi.nlm.nih.gov/pubmed/28572122 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/13993003.01838-2016 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|